Skip to main content

Immunizations and Autism: A Review of the Literature

  • Asif Doja (a1) and Wendy Roberts (a2)

Because of a temporal correlation between the first notable signs and symptoms of autism and the routine childhood vaccination schedule, many parents have become increasingly concerned regarding the possible etiologic role vaccines may play in the development of autism. In particular, some have suggested an association between the Measles-Mumps-Rubella vaccine and autism. Our literature review found very few studies supporting this theory, with the overwhelming majority showing no causal association between the Measles-Mumps-Rubella vaccine and autism. The vaccine preservative thimerosal has alternatively been hypothesized to have a possible causal role in autism. Again, no convincing evidence was found to support this claim, nor for the use of chelation therapy in autism. With decreasing uptake of immunizations in children and the inevitable occurrence of measles outbreaks, it is important that clinicians be aware of the literature concerning vaccinations and autism so that they may have informed discussions with parents and caregivers.


Plusieurs parents s’inquiètent que des vaccins puissent jouer un rôle étiologique dans le développement de l’autisme à cause d’une corrélation temporelle entre les premiers signes et symptômes décelables de l’autisme et le calendrier vaccinal. Une association entre le vaccine contre la rougeole, les oreillons et la rubéole et l‘autisme a été suggérée. Cette revue de la littérature a retrouvé peu d’études à l’appui de cette théorie, la très grande majorité des études ne démontrant pas d’association entre ce vaccine et l’autisme. On a d’autre part émis l’hypothèse d’un lien causal possible entre le thimerosal, un agent de conservation, et l’autisme. Là non plus, nous n’avons pas trouvé de données convaincantes à l’appui de cette hypothèse ou du traitement par chélation dans l’autisme. Avec la diminution du taux d’immunisation chez les enfants et l’apparition inévitable d’épidémies de rougeole, il est important que les cliniciens soient au courant de la littérapture portant sur la vaccination et l’autisme afin qu’ils puissent en discuter en connaissance de cause avec les parents et les soignants.

    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Immunizations and Autism: A Review of the Literature
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Immunizations and Autism: A Review of the Literature
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Immunizations and Autism: A Review of the Literature
      Available formats
Corresponding author
Division of Neurology, Children’s Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, Ontario, K1H 8L1, Canada
Hide All
1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington D.C: American Psychiatric Association; 1994.
2. Bryson SE, Smith IM. Epidemiology of autism: Prevalence, associated characteristics and implications for research and service delivery. Mental Retard Dev Disab Res Rev. 1998; 000:17.
3. Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Measles-mumps-rubella vaccine and autistic spectrum disorder: a hypothesis only. Paediatr Child Health. 2001; 6:38791.
4. Fombonne E. Is there an epidemic of autism? Pediatrics. 2001; 107:4112.
5. Roberts W, Harford M. Immunization and children at risk for autism. Paediatr Child Health. 2002; 7:62332.
6. American Academy of Pediatrics Committee on Infectious Diseases. Red Book. 26th ed. Elk Grove Village Il: American Academy of Pediatrics; 2003.
7. Filipek PA, Accardo JA, Baranek GT, Cook EH Jr, Dawson G, Gordon B, et al. The screening and diagnosis of autistic spectrum disorders. J Aut Dev Dis. 1999; 29:43984.
8. Wakefield AJ, Murch SH, Linnell AJ, Casson DM, Malik M, Berelowitz M, et al. Ileal-lymphoid-nodular hyperplasia, nonspecific colitis, and pervasive developmental disorder in children. Lancet. 1998; 351:63741.
9. Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet. 1995; 345:10714.
10. Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, Davies S, et al. Enterocolitis in children with developmental disorders. Am J Gastro. 2000; 95:228595.
11. Halsey N, Hyman S. Conference writing panel. Measles, Mumps and Rubella Vaccine and Autism Spectrum Disorder. Report from the New Challenges in Childhood Immunization Conference convened at Oak Brook, Illinois, June 12-13, 2001. Pediatrics. 2001; 107:123.
12. Wakefield AJ, Pittilo RM, Sim R, Cosby SL, Stephenson JR, Dhillon AP, et al. Evidence of persistent measles virus infection in Chron’s disease. J Med Virol. 1993; 39:34553.
13. Uhlman V, Martin CM, Shiels O, Pilkington L, Silva I, Killalea A, et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol. 2002; 55:8490.
14. Afzal MA, Armitage E, Begley J, Bentley ML, Minor PD, Ghosh S et al. Absence of detectable measles virus genome sequence in inflammatory bowel disease tissues and peripheral blood lymphocytes. J Med Virol. 1998; 55:2439.
15. Iizuka M, Itou H, Chiba M, Shirasaka T, Watanabe S, et al. The MMR question. Lancet. 2000; 356:160.
16. Singh VK, Lin SX, Newell E, Nelson C. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci. 2002; 9: 35964.
17. Davis R. MMR and autism: a report for the Global Advisory Committee on Vaccine Safety. Available from: davis.pdf. [Cited: 2005 Aug 24].
18. Deer Brian. “Revealed: MMR reseach scandal. The Sunday Times (London). 2004 Feb 22.
19. Murch SH, Anthony A, Casson DH, Malik M, Berelowitz M, Dhillon AP, et al. Retraction of an interpretation. Lancet. 2004; 363:750.
20. Wilson K, Mills E, Ross C, McGowan J, Jaddad A. Association of autistic spectrum disorder and the measles, mumps and rubella vaccine: a systematic review of current epidemiological evidence. Arch Pediatr Adolesc Med. 2003; 157:62834.
21. Madsen KM, Hvid A, Vestergaard M, Schendel D, Wohlfahrt J Thornsen P, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002; 347:147782.
22. Taylor B, Miller E, Farringtom CP, Petropoulos MC, Favot-Mayaud I, Li J, et al. Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999; 353:202629.
23. Kaye JA, Melero-Montes MM, Jick H. Mumps, measles and rubella vaccine and the incidence of autism recorded by general practioners: a time trend analysis. BMJ. 2001; 322:4603.
24. Dales L, Hammer SJ, Smith NJ. Time trends in autism and MMR immunization coverage in California. JAMA. 2001; 286:11835.
25. Honda H, Shimizu Y, Rutter M. No effect of MMR withdrawal on the incidence of autism: a total population study. J Child Psych Psychol. 2005; 46:57279.
26. Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, Smith PG, et al. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet. 2004; 364:9639.
27. Makela A, Nuorti JP, Petola H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics. 2002; 110:95763.
28. Fombonne E, Chakrabart S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics. 2001; 108:18.
29. Petola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet. 1998; 351: 13278.
30. Black C, Kaye JA, Jick H. Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Database. BMJ. 2002; 325:41921.
31. Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ. 2002; 324:3936.
32. Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics. 2004; 114:793804.
33. US Environmental Protection Agency Mercury study report to congress: volume IV: an assessment of exposure to mercury in the United States. Available from: [Cited: 2005 Aug 24].
34. Food and Drug Administration. Thimerosal in vaccines. Available from [Cited: 2005 Aug 24].
35. Health Canada. Exposure to thimerosal in vaccines used in Canadian infant immunization programs with respect to risk of neurodevelopmental disorders. Can Commun Dis Rep 2002; 28:2869.
36. Nelson KB, Bauman ML. Thimerosal and autism? Pediatrics. 2003; 111: 6749.
37. Kerper LE, Ballagtori N, Clarkson TW. Methylmercury transport across the blood-brain barrier by an amino acid carrier. Am J Physiol. 1992;262:R7615.
38. Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: a novel form of mercury poisoning. Med Hypotheses. 2001; 56:46271.
39. Ip P, Wong V, Ho M, Lee J, Wong W. Mercury exposure in children with autistic spectrum disorder: case-control study. J Child Neurol. 2004; 19:4314.
40. Pichichero ME, Cernichiari E, Lopreiato J, Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thimerosall: a descriptive study. Lancet. 2002; 360:173741.
41. Holmes AS, Blaxill MF, Haley BE. Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol. 2003; 22:27785.
42. Geier MR, Geier DA. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exp Biol Med. 2003; 228:6604.
43. Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics. 2003; 112:103948.
44. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccines and autism. JAMA. 2003; 290:17636.
45. Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics. 2004; 114:58491.
46. Madsen K, Lauritsen M, Pedersen C, Thorsen P, Plesner AM, Anderson PH, et al. Thimerosal and the occurrence of autism? Negative ecological evidence from Danish population-based data. Pediatrics. 2003; 112:6046.
47. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004; 80:16117.
48. James SJ, Slikker W, Melnyk S, New E, Pogribna M, Jernigan S. Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. Neurotoxicology. 2005; 26:18.
49. Waly M, Olteanu H, Banerjee R, Choi SW, Mason JB, Parker BS, et al. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psych. 2004; 1-13.
50. Shannon M, Levy S, Sandler A. Chelation therapy neither safe nor effective as autism treatment. AAP news. 2001:63.
51. The Times. Autistic boy, 5, dies after US therapy. August 26, 2005. Available from: (,2-1751 753,00.html) Cited: October 12, 2005.
52. World Health Organization. Global Advisory Committee on Vaccine Safety, 16-17 December 2002: MMR and autism. Weekly Epidemiological Record Available from: [Cited: 2005 Aug 24].
53. Moms Against Mercury. Available from: http://www.momsagainst [Cited: 2006 May 2].
54. Institute of Medicine of the National Academies. Immunization safety review: Vaccines and autism. Available from [Cited: 2005 Aug 24].
55. Public Health Agency of Canada. Disease information measles Available from: [Cited: 2005 Aug 24].
56. Public Health Agency of Canada. Measles Available from: [Cited: 2005 Aug 24].
57. Department of Health. Statistical bulletin. NHS Immunization Statistics, England. Available from: calHealthCare/StatisticalHealthCareArticle/fs/en?CONTENT_I D=4086491&chk=LUyYGS. [Cited: 2005 Aug 24].
58. Jansen VA, Stollenwerk N, Jensen HJ, Ramsay Me, Edmunds WJ, Rhodes CJ. Measles outbreaks in populations with declining vaccine uptake. Science. 2003; 301:804.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Canadian Journal of Neurological Sciences
  • ISSN: 0317-1671
  • EISSN: 2057-0155
  • URL: /core/journals/canadian-journal-of-neurological-sciences
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score

Full text views

Total number of HTML views: 10
Total number of PDF views: 3946 *
Loading metrics...

Abstract views

Total abstract views: 4400 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 17th February 2018. This data will be updated every 24 hours.